Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
30 nov 2010 - 23:59
Statutaire naam
Crucell N.V.
Titel
Johnson & Johnson and Crucell Progress Update: Expect to Commence Public Offer Prior to 10 December 2010
Bericht
Johnson & Johnson and Crucell Progress Update:
Expect to Commence Public Offer Prior to 10 December 2010
Will further assess Korea Manufacturing Issues following Commencement of Offer
New Brunswick, N.J., and Leiden, the Netherlands, 30 November 2010 – Johnson & Johnson (NYSE: JNJ) and Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) provide the following joint update on the preparations for the intended public offer by JJC Acquisition Company B.V., a subsidiary of Johnson & Johnson, for all ordinary shares and American depository receipts of Crucell (the Offer) and on the status of the manufacturing issues in Crucell’s Shingal facility in Korea previously announced by Crucell (the Korea Manufacturing Issues ).
Datum laatste update: 20 december 2025